← Browse by Condition
Medical Condition
osteoporosis
Total Trials
12
Recruiting Now
12
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for osteoporosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — osteoporosis Clinical Trials
How many clinical trials are currently recruiting for osteoporosis?
ClinicalMetric currently tracks 12 actively recruiting clinical trials for osteoporosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteoporosis?
osteoporosis research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteoporosis clinical trial?
Eligibility criteria for osteoporosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05266976
Recruiting
Enrollment
120 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT07597850 Phase 2
Recruiting
Enrollment
90 pts
Location
Taiwan
Sponsor
Tri-Service General Hospital (...
NCT06455085
Recruiting
Enrollment
2,634 pts
Location
United States
Sponsor
University of Alabama at Birmi...
NCT07546552
Recruiting
Enrollment
100 pts
Location
Denmark
Sponsor
Peter Humaidan
NCT07651306
Recruiting
Enrollment
65 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul Physical Medicine Reh...
NCT07616401
Recruiting
Enrollment
42 pts
Location
Italy
Sponsor
Istituto Auxologico Italiano
NCT07303166
Recruiting
Enrollment
15 pts
Location
France
Sponsor
University Hospital, Strasbour...
NCT05732870
Recruiting
Enrollment
2,000 pts
Location
United Kingdom
Sponsor
Relation Therapeutics
NCT06449742
Recruiting
Enrollment
250 pts
Location
Italy
Sponsor
IRCCS San Raffaele
NCT06608862
Recruiting
Enrollment
150 pts
Location
Germany
Sponsor
Bundeswehr University Munich
NCT07141043
Recruiting
Enrollment
180 pts
Location
Romania
Sponsor
Grigore T. Popa University of ...
NCT05246813
Recruiting
Enrollment
24 pts
Location
Belgium
Sponsor
Imelda Hospital, Bonheiden
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology